Tachykinins induce secretion of prolactin from perifused rat anterior pituitary cells by interactions with two different binding sites.
Substance P and the two other mammalian tachykinins, neurokinin A and B, are accepted to have direct regulating effects at the anterior pituitary level. We have examined the effects of substance P (SP) and neurokinin B (NKB), alone and in combination, on prolactin release from cultured anterior pituitary cells grown on collagen-coated micro beads and placed in a perfusion system. Prolactin (Prl) secretion was observed within 25 s after exposure to either secretagogue and reached a maximum within 60-80 s. Furthermore, the prolactin response induced by SP and NKB was dose-dependent. Prl secretion remained constant for up to 4 h when SP or NKB were perifused and then fell gradually towards basal levels. Simultaneous addition of submaximal concentrations of SP and NKB resulted in an additive response compared with the responses of either secretagogue alone. Continuous (8 h) perifusion with SP did not prevent a normal prolactin response by NKB or TRH. These results indicate that the tachykinins, substance P and neurokinin B, release Prl from perifused female rat anterior pituitary cells by interaction with two different receptors, possibly the NK1 and NK3 tachykinin receptor subtypes.
Henriksen
J S
JS
Division of Endocrinology and Metabolism, The Panum Institute, University of Copenhagen, Denmark.
Saermark
T
T
Vilhardt
H
H
Mau
S E
SE
D000818:Animals; D001665:Binding Sites; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D015287:Neurokinin B / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D010903:Pituitary Gland, Anterior / Q000187:drug effects* / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D018040:Receptors, Neurokinin-1 / Q000187:drug effects / Q000378:metabolism; D018042:Receptors, Neurokinin-3 / Q000187:drug effects / Q000378:metabolism; D013373:Substance P / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*
D018040:Receptors, Neurokinin-1; D018042:Receptors, Neurokinin-3; D013373:Substance P; D015287:Neurokinin B; D011388:Prolactin